Grace Therapeutics Inc (GRCE) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Grace Therapeutics Inc  (NASDAQ: GRCE)


Grace Therapeutics Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Grace Therapeutics Inc's ROI in the first quarter of 2026?
Grace Therapeutics Inc recorded a cumulative net loss of $-20 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -30.17%.

Within the Healthcare sector 291 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 3666 to 3994.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Investment Change TTM -8.24 % -1.79 % -1.7 % -2.61 % -7.67 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 48 75 79 65 67
Return On Investment (TTM) -30.17 % -10.87 % -8.23 % -10.62 % -14.12 %
GRCE's Overall Ranking # 3994 # 3666 # # #
Seq. Investment Change TTM -6.55 % -1.33 % -1.25 % 0.77 % 0.02 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -20 -8 -6 -8 -10

GRCE Company Profile >> Back to GRCE Roi Comparisons >> See Annual GRCE Return On Investment



Return On Investment GRCE's Ranking
Within: No.
Industry # 111
Sector # 292
Overall # 3994

Return On Investment Statistics
High Average Low
18.73 %
-22.12 %
-78.26 %
(Dec 31 2020)  







Financial Statements
Grace Therapeutics Inc's I. Quarter Investments $ 48 Millions GRCE's Balance sheet
Grace Therapeutics Inc's I. Quarter Income $ -16 Millions Quarterly GRCE's Income Statement
GRCE's Income by Division See GRCE's Income by Division


GRCE Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022
Total Investments in Millions 75 79 83 90 146
Y / Y Investment Growth -4.86 % -4.43 % -7.3 % -38.82 % 140.37 %
Net Income in Millions -8 -10 -13 -42 -10
Y / Y Net Income Growth - - - - -
Annual Return On Investment -10.33 % -12.06 % -15.49 % -47.39 % -6.71 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
GRCE's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for GRCE's Competitors
Subscribers only: Roi for Grace Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for GRCE's Customers

Other Ratios
GRCE's Roa GRCE's Inventory Turnover Ratio GRCE's Growth Rates GRCE's Dividend Statistics
GRCE's Profitability Ratios GRCE's Asset Turnover Ratio GRCE's Dividend Growth
GRCE's Roe GRCE's Valuation Ratios GRCE's Financial Strength Ratios GRCE's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:38:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.